{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:47:31Z","timestamp":1792439251354,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000976","name":"Argosy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.contraception.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:06:49Z","timestamp":1618967209000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7218-3075","authenticated-orcid":false,"given":"Danielle","family":"Calloway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra B.","family":"Stulberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Janiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.contraception.2021.04.002_bib0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.002_bib0002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2009.03.010","article-title":"Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days","volume":"80","author":"Fjerstad","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2021.04.002_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days","volume":"61","author":"Schaff","year":"2000","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2021.04.002_bib0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.contraception.2020.01.009","article-title":"A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation","volume":"101","author":"Dzuba","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.002_bib0005","unstructured":"Reproductive Decisions, Promoting access to medication and first trimester aspiration terminations by supporting skilled providers [Internet]. AAFP Home, 2019. Accessed January 5, 2021. Available at: https:\/\/www.aafp.org\/about\/policies\/all\/reproductive-decisions-promoting-access.html"},{"issue":"18","key":"10.1016\/j.contraception.2021.04.002_bib0006","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1056\/NEJMp1903572","article-title":"Responding to evolving abortion regulations\u2014the critical role of primary care","volume":"380","author":"Beaman","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.contraception.2021.04.002_bib0007","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3122\/jabfm.18.4.304","article-title":"Medication abortion and family physicians' scope of practice","volume":"18","author":"Prine","year":"2005","journal-title":"J Am Board Fam Pract"},{"issue":"8","key":"10.1016\/j.contraception.2021.04.002_bib0008","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s11606-020-05836-9","article-title":"Medication to manage abortion and miscarriage","volume":"35","author":"Beaman","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.contraception.2021.04.002_bib0009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.contraception.2018.01.002","article-title":"Provision of abortion and other reproductive health services among former Midwest Access Project trainees","volume":"97","author":"Stulberg","year":"2018","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.002_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.contraception.2019.05.011","article-title":"Intention to provide abortion upon completing family medicine residency and subsequent abortion provision: a 5-year follow-up survey","volume":"100","author":"Srinivasulu","year":"2019","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2021.04.002_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1363\/psrh.12015","article-title":"Abortion incidence and service availability in the United States, 2014","volume":"49","author":"Jones","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"issue":"23","key":"10.1016\/j.contraception.2021.04.002_bib0012","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss","volume":"378","author":"Schreiber","year":"2018","journal-title":"N Engl J Med"},{"issue":"10253","key":"10.1016\/j.contraception.2021.04.002_bib0013","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(20)31788-8","article-title":"Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Chu","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.contraception.2021.04.002_bib0014","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/1471-0528.14900","article-title":"Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial","volume":"124","author":"Shaw","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2021.04.002_bib0015","unstructured":"Center for Drug Evaluation and Research. FAQs about REMS [Internet]. U.S. Food and Drug Administration, 2018. Accessed January 5, 2021. Available at: https:\/\/www.fda.gov\/drugs\/risk-evaluation-and-mitigation-strategies-rems\/frequently-asked-questions-faqs-about-rems"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.002_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.contraception.2005.03.011","article-title":"Safety of mifepristone abortions in clinical use","volume":"72","author":"Henderson","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2021.04.002_bib0017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2020.04.012","article-title":"Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services","volume":"102","author":"Yalahow","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.002_bib0018","unstructured":"Government of Canada HC. Health Canada approves updates to Mifegymiso prescribing information: ultrasound no longer mandatory [Internet]. Recalls and Safety Alerts, 2019. Accessed January 5, 2021. Available at: https:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2019\/69620a-eng.php"},{"key":"10.1016\/j.contraception.2021.04.002_sbref0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsrh-2020-200880","article-title":"Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis","author":"Aiken","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2021.04.002_bib0020","series-title":"Expanding access expanding access to medication abortion through pharmacy dispensing of mifepristone: primary care perspective through Illinois [Internet]","author":"Rasmussen","year":"2020"},{"issue":"6","key":"10.1016\/j.contraception.2021.04.002_bib0021","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13691050902842741","article-title":"Conceptualising abortion stigma","volume":"11","author":"Kumar","year":"2009","journal-title":"Cult Health Sex"},{"issue":"7","key":"10.1016\/j.contraception.2021.04.002_bib0022","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.socscimed.2011.07.004","article-title":"Dynamics of stigma in abortion work: findings from a pilot study of the Providers Share Workshop","volume":"73","author":"Harris","year":"2011","journal-title":"Soc Sci Med"},{"issue":"9","key":"10.1016\/j.contraception.2021.04.002_bib0023","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.socscimed.2011.08.019","article-title":"Resistance and vulnerability to stigmatization in abortion work","volume":"73","author":"O'Donnell","year":"2011","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.contraception.2021.04.002_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diaspect.17.2.97","article-title":"The breakthrough series: IHI's collaborative model for achieving breakthrough improvement","volume":"17","year":"2004","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.contraception.2021.04.002_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.childyouth.2015.06.005","article-title":"Statewide dissemination of an evidence-based practice using Breakthrough Series Collaboratives","volume":"55","author":"Lang","year":"2015","journal-title":"Children Youth Serv Rev"},{"issue":"10","key":"10.1016\/j.contraception.2021.04.002_bib0026","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2105\/AJPH.2013.301776","article-title":"Use of a learning collaborative to support implementation of integrated care for smoking cessation for veterans with posttraumatic stress disorder","volume":"104","author":"Ebert","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2021.04.002_bib0027","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/1552-6909.12453","article-title":"Improving outcomes of preeclampsia in California: from review of maternal death to quality care collaboratives","volume":"43","author":"Morton","year":"2014","journal-title":"J Obstetr Gynecol Neonatal Nurs"},{"issue":"suppl 1","key":"10.1016\/j.contraception.2021.04.002_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10995-016-2170-2","article-title":"The Ohio Gestational Diabetes Postpartum Care Learning Collaborative: development of a quality improvement initiative to improve systems of care for women","volume":"20","author":"Shellhaas","year":"2016","journal-title":"Matern Child Health J"},{"issue":"6","key":"10.1016\/j.contraception.2021.04.002_bib0029","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.002_bib0030","unstructured":"State funding of abortion under Medicaid Guttmacher Institute [Internet.]. Guttmacher Institute, 2021. Accessed January 19, 2021. Available at: https:\/\/www.guttmacher.org\/state-policy\/explore\/state-funding-abortion-under-medicaid"},{"key":"10.1016\/j.contraception.2021.04.002_bib0031","unstructured":"Regulating insurance coverage of abortion Guttmacher Institute [Internet.]. Guttmacher Institute, 2021. Accessed January 19, 2021. Available at: https:\/\/www.guttmacher.org\/state-policy\/explore\/regulating-insurance-coverage-abortion"},{"issue":"3 suppl","key":"10.1016\/j.contraception.2021.04.002_bib0032","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.whi.2011.02.010","article-title":"Abortion stigma: a reconceptualization of constituents, causes, and consequences","volume":"21","author":"Norris","year":"2011","journal-title":"Womens Health Issues"},{"issue":"4","key":"10.1016\/j.contraception.2021.04.002_bib0033","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1363\/48e8516","article-title":"Abortion stigma: a systematic review","volume":"48","author":"Hanschmidt","year":"2016","journal-title":"Perspect Sex Reprod Health"},{"issue":"2","key":"10.1016\/j.contraception.2021.04.002_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2015.10.008","article-title":"Eliminating the phrase \"elective abortion\": why language matters","volume":"93","author":"Janiak","year":"2016","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2021.04.002_bib0035","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0959353518765572","article-title":"Disgust, stigma, and the politics of abortion","volume":"28","author":"Kumar","year":"2018","journal-title":"Fem Psychol"},{"issue":"1","key":"10.1016\/j.contraception.2021.04.002_bib0036","first-page":"22","article-title":"The effects of abortion training on family medicine residents' clinical experience","volume":"49","author":"Summit","year":"2017","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2021.04.002_bib0037","unstructured":"Training in early abortion for comprehensive healthcare Guttmacher Institute [Internet.]. TEACH. Accessed February 4, 2021. Available at: https:\/\/www.teachtraining.org\/"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:11:40Z","timestamp":1762117900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0010782421001050"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}